SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr | ₹-1.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹63 Cr |
Mar2023 | ₹0.58 Cr |
Mar2022 | ₹-2.45 Cr |
Mar2017 | ₹0.83 Cr |
Mar2016 | ₹-1.08 Cr |
How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹63 Cr | 10,713.84 | |
Mar2023 | ₹0.58 Cr | Positive | |
Mar2022 | ₹-2.45 Cr | Negative | |
Mar2017 | ₹0.83 Cr | Positive | |
Mar2016 | ₹-1.08 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,414.7 Cr | -8.6% | -12.4% | 14.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -8.6% |
-12.4% |
14.3% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses